Mateusz Kaczmarek, Author at Tech Space 2.0

Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Import Fair 2025: Turning Imports into Local Industry Uzbekistan’s capital Tashkent buzzed with business activity as the country opened the First International Uzbek Import Fair 2025. The exhibition, held at the Uzexpocentre

9 October 2025

United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

Stock Price & Recent Performance As of market close Oct 8, 2025, UAL traded around $98.09 reuters.com, a ~1.5% gain for the day. In early pre-market Oct 9, it had jumped ~6%

9 October 2025

Airlines · Financial News · Investing · Stock Market · Travel Industry

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Company Overview: A Near-Patient Diagnostics Specialist Bluejay Diagnostics, Inc. is a small Massachusetts-based medical diagnostics company focused on rapid near-patient testing solutions for critical care settings stocktitan.net. The company’s mission is to

9 October 2025

Diagnostics · Healthcare News · Investing · Medical Technology · Stock Market

AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next

Latest News (Oct 7–Oct 9, 2025) Stock Performance & Technical Analysis After languishing through the summer, Recursion’s share price came to life in early October 2025. By Oct 8 the stock had

9 October 2025

Artificial Intelligence · Biotechnology · Drug Discovery · Pharma Industry · Stock Market

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

Stock Price and Recent Performance American Airlines’ stock has been on a turbulent ride in 2025. After starting the year in the high teens, AAL has sunk into the low double-digits –

9 October 2025

Airlines · Investment · Market Analysis · Stock Market · Travel Industry

Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Latest News & Developments (October 2025) Serve Robotics grabbed headlines this week with a major new partnership announcement. On October 9, 2025, the company revealed a deal with DoorDash to deploy Serve’s

9 October 2025

Artificial Intelligence · Delivery Services · Investing · Stock Market · Technology News

Gold Hits $4,000 Record, Silver Soars to $50 – Rally to Continue or Crash Ahead?

Precious Metals Skyrocket to Historic Highs Gold and silver have been on a record-breaking tear in 2025. Gold entered the year around $2,800 and by October blasted past the $4,000/oz milestone –

9 October 2025

Gold Market · Investment Trends · Market Analysis · Precious Metals · Silver Prices

Jefferies Scrambles as First Brands’ $10 Billion Bankruptcy Reveals $2.3 Billion in ‘Vanished’ Debt

First Brands’ Debt-Fueled Rise and Spectacular Fall First Brands Group’s journey from industry consolidator to bankruptcy cautionary tale was swift and dramatic. The company – a leading supplier of replacement auto parts

9 October 2025

Bankruptcy · Corporate News · Debt Analysis · Finance · Investment

Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

Record Highs Amid a Tech-Fueled Rally Wall Street’s momentum in 2025 is undeniable – and increasingly historic. Stocks have been on a tear, repeatedly smashing records. After seven consecutive daily gains to

9 October 2025

Economic Outlook · Federal Reserve · Financial News · Investments · Stock Market

Nvidia’s $2B Bet on Reflection AI Shakes Up the Global AI Race

Reflection AI’s $2B Funding Frenzy It’s official: Reflection AI has secured one of the largest funding rounds ever for a young tech startup – $2 billion in fresh capital led by Nvidia

9 October 2025

Artificial Intelligence · Global Markets · Innovation · NVIDIA · Tech News

Wolfspeed WOLF Stock’s Wild Comeback: From Bankruptcy to Boom – Price, News & Expert Forecasts

Wolfspeed, Inc. (NYSE: WOLF) has seen a stunning reversal in fortune. As of October 9, 2025, the stock trades around $30.36 per share, giving the company a market capitalization of roughly $0.7–0.8

9 October 2025

Company Analysis · Expert Opinions · Financial News · Investing · Stock Market

Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback?

Company Overview: Pioneering T-Cell Therapies for Cancer Adaptimmune Therapeutics plc is a UK-based biotech founded in 2008, specializing in T-cell receptor (TCR) engineered cell therapies to fight cancer ts2.tech. The company’s mission

9 October 2025

Biotech Stocks · Financial News · Investment Strategies · Market Analysis · Stock Trends